机构:[1]Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China华中科技大学同济医学院附属协和医院[2]Department of Hematology, Xiangya Third Hospital, Central South University, Changsha, Hunan 410013, China[3]Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China[4]Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250063, China[5]Institute of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China浙江大学医学院附属第一医院[6]Peking University People’s Hospital, Peking University Institute of Hematology, Beijing 100044, China[7]Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China南方医科大学珠江医院[8]Department of Hematology, Tongji Hospital of Tongji University, Shanghai 200092, China[9]Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China[10]Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China四川大学华西医院[11]Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China[12]Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan 450008, China河南省肿瘤医院[13]State Key Laboratory of Experimental Hematology and National Clinical Research Center for Blood Disease, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China[14]Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China[15]Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China[16]Department of Hematology, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, China[17]Medical Center of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing 400037, China[18]Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China[19]Molecular and Immunological Department, Chinese People’s Liberation Army General Hospital, Beijing 100853, China[20]Bio-Therapeutic Department, Chinese People’s Liberation Army General Hospital, Beijing 100853, China[21]Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.华中科技大学同济医学院附属协和医院
第一作者机构:[1]Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China[*2]Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China
通讯作者:
通讯机构:[1]Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China[19]Molecular and Immunological Department, Chinese People’s Liberation Army General Hospital, Beijing 100853, China[20]Bio-Therapeutic Department, Chinese People’s Liberation Army General Hospital, Beijing 100853, China[21]Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.[*1]Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan, Hubei 430022, China[*2]Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China[*3]Chinese People’s Liberation Army General Hospital, No. 28 Fuxing Road, Beijing 100853, China
推荐引用方式(GB/T 7714):
Mei Heng,Chen Fangping,Han Yue,et al.Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy[J].CHINESE MEDICAL JOURNAL.2022,135(14):1639-1641.doi:10.1097/CM9.0000000000002288.
APA:
Mei Heng,Chen Fangping,Han Yue,Hou Ming,Huang He...&Hu Yu.(2022).Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy.CHINESE MEDICAL JOURNAL,135,(14)
MLA:
Mei Heng,et al."Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy".CHINESE MEDICAL JOURNAL 135..14(2022):1639-1641